Encore Medical $165 million eight-year notes talked at 9 5/8% to 9 7/8%

By Paul A. Harris

St. Louis, Sept. 24 - Encore Medical IHC Inc.'s $165 million offering of eight-year senior subordinated notes (Caa1/CCC+) emerged with price talk of 9 5/8% to 9 7/8% Friday, according to an informed source.

The deal is expected to price on Tuesday morning.

Banc of America Securities is the bookrunner for the Rule 144A offering. Albany Capital is the co-manager.

The notes will come with four years of call protection.

Proceeds will be used to fund Encore's $360 million acquisition of EMPI Inc.

Encore Medical is an Austin, Texas-based diversified orthopedic device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.